Question 1

What is the catalog number for ADORA2B Antibody?

Accepted Answer

The catalog number for ADORA2B Antibody is 8G203-AAT.

Question 2

What sizes are available for ADORA2B Antibody?

Accepted Answer

ADORA2B Antibody is available in the following size(s): 50 µg.

Question 3

Is ADORA2B Antibody in stock?

Accepted Answer

ADORA2B Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Who manufactures ADORA2B Antibody?

Accepted Answer

ADORA2B Antibody is manufactured by AAT Bioquest.

Question 5

What is the estimated delivery time for ADORA2B Antibody?

Accepted Answer

Estimated delivery time for ADORA2B Antibody is approximately 15 business day(s), depending on your location.

Question 6

What is ADORA2B Antibody used for?

Accepted Answer

ADORA2B Antibody

Question 7

What is the isotype of this antibody?

Accepted Answer

Isotype information such as IgG1 or IgG2a is listed in the product specifications on the datasheet, relevant for selecting compatible detection reagents.

Question 8

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 9

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

ADORA2B Antibody

Product Specifications

H Phrases

R Phrases

Host

Reactivity

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

Recombinant SGK1 Antibody

Recombinant SGK1 Antibody

Recombinant SGK1 Antibody

CD45 / LCA (B-Cell Marker) (rPTPRC/1460), CF594 conjugate, 0.1mg/mL

DUSP3 (N-term) Rabbit Polyclonal Antibody

OR2T33 Human Gene Knockout Kit (CRISPR)